Chemokine production by human vascular smooth muscle cells: modulation by IL‐13
1 The production of chemokines by vascular smooth muscle cells (SMC) is implicated in the pathogenesis of atherosclerosis, although the factors regulating chemokine production by these cells are incompletely characterized. 2 We describe the differential stimulation of interleukin‐(IL)‐8, monocyte ch...
Gespeichert in:
| Veröffentlicht in: | British journal of pharmacology 1997-10, Vol.122 (4), p.749-757 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 757 |
|---|---|
| container_issue | 4 |
| container_start_page | 749 |
| container_title | British journal of pharmacology |
| container_volume | 122 |
| creator | Jordan, Nicola J. Watson, Malcolm L. Williams, Robert J. Roach, Alan G. Yoshimura, Teizo Westwick, John |
| description | 1
The production of chemokines by vascular smooth muscle cells (SMC) is implicated in the pathogenesis of atherosclerosis, although the factors regulating chemokine production by these cells are incompletely characterized.
2
We describe the differential stimulation of interleukin‐(IL)‐8, monocyte chemoattractant protein (MCP)‐1 and regulated on activation normal T‐cell expressed and secreted (RANTES) synthesis following treatment of human vascular SMC with IL‐1α or tumour necrosis factor α (TNFα). Under basal conditions, cultured SMC release very low amounts of IL‐8, MCP‐1 and RANTES as assessed by specific ELISA. Concentration‐response studies with IL‐1α or TNFα revealed that each stimulus induced a similar amount of MCP‐1. In contrast approximately three fold more IL‐8 was induced by IL‐1α than by TNFα whereas significant RANTES production was induced only by TNFα. These findings point to a divergence in the regulation of synthesis of the different chemokines in response to IL‐1α or TNFα stimulation.
3
The T‐cell derived cytokines IL‐10 and IL‐13 were also found to have differential effects on chemokine production by SMC. IL‐13, but not IL‐10, significantly enhanced IL‐8 and MCP‐1 release in response to IL‐1α or TNFα. This increase in chemokine release appeared to be accounted for by increased mRNA expression.
4
These findings provide support for the concept that smooth muscle cells can have an active role in a local immune response via the production of chemokines which can be selectively modulated by T‐cell derived cytokines.
British Journal of Pharmacology (1997) 122, 749–757; doi:10.1038/sj.bjp.0701433 |
| doi_str_mv | 10.1038/sj.bjp.0701433 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1564990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79432888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5245-6c1d05e92a71b284c9d7f537448236492394d9eef6bfcf745386e72c91e27f893</originalsourceid><addsrcrecordid>eNqFUU1P2zAYttBQKWxXbkg5TLul-DO2OUzaKj4qVWKTtrPlOA5NceJiN0y98RP4jfwSXDVU7MTJh-fL7_MAcIrgBEEizuNyUi5XE8ghooQcgDGivMgZEegTGEMIeY6QEEfgOMYlTBzO2QiMJOFMcjIGv6cL2_r7prPZKviqN-vGd1m5yRZ9q7vsUUfTOx2y2Hq_XmRtH42zmbHOxYusTQKn3xSz-cvTMyKfwWGtXbRfhvcE_L26_DO9yee317Ppj3luGKYsLwyqILMSa45KLKiRFa8Z4ZQKTAoqMZG0ktbWRVmbmtN0UWE5NhJZzGshyQn4vvNd9WVrK2O7ddBOrULT6rBRXjfqf6RrFurOPyrEkr2EyeDbYBD8Q2_jWrVN3F6mO-v7qLikBAshEnGyI5rgYwy23ocgqLYjqLhUaQQ1jJAEZ--_tqcPrSf864CnerWrg-5ME_c0LBglfJtLdrR_jbObD0LVz183BUk1vQKedqHz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79432888</pqid></control><display><type>article</type><title>Chemokine production by human vascular smooth muscle cells: modulation by IL‐13</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Jordan, Nicola J. ; Watson, Malcolm L. ; Williams, Robert J. ; Roach, Alan G. ; Yoshimura, Teizo ; Westwick, John</creator><creatorcontrib>Jordan, Nicola J. ; Watson, Malcolm L. ; Williams, Robert J. ; Roach, Alan G. ; Yoshimura, Teizo ; Westwick, John</creatorcontrib><description>1
The production of chemokines by vascular smooth muscle cells (SMC) is implicated in the pathogenesis of atherosclerosis, although the factors regulating chemokine production by these cells are incompletely characterized.
2
We describe the differential stimulation of interleukin‐(IL)‐8, monocyte chemoattractant protein (MCP)‐1 and regulated on activation normal T‐cell expressed and secreted (RANTES) synthesis following treatment of human vascular SMC with IL‐1α or tumour necrosis factor α (TNFα). Under basal conditions, cultured SMC release very low amounts of IL‐8, MCP‐1 and RANTES as assessed by specific ELISA. Concentration‐response studies with IL‐1α or TNFα revealed that each stimulus induced a similar amount of MCP‐1. In contrast approximately three fold more IL‐8 was induced by IL‐1α than by TNFα whereas significant RANTES production was induced only by TNFα. These findings point to a divergence in the regulation of synthesis of the different chemokines in response to IL‐1α or TNFα stimulation.
3
The T‐cell derived cytokines IL‐10 and IL‐13 were also found to have differential effects on chemokine production by SMC. IL‐13, but not IL‐10, significantly enhanced IL‐8 and MCP‐1 release in response to IL‐1α or TNFα. This increase in chemokine release appeared to be accounted for by increased mRNA expression.
4
These findings provide support for the concept that smooth muscle cells can have an active role in a local immune response via the production of chemokines which can be selectively modulated by T‐cell derived cytokines.
British Journal of Pharmacology (1997) 122, 749–757; doi:10.1038/sj.bjp.0701433</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0701433</identifier><identifier>PMID: 9375973</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cells, Cultured ; Chemokine ; Chemokines - biosynthesis ; Chemokines - genetics ; Chemokines - secretion ; Gene Expression Regulation ; Humans ; IL‐10 ; IL‐13 ; IL‐8 ; interleukin (IL)‐1α ; Interleukin-10 - pharmacology ; Interleukin-13 - pharmacology ; MCP‐1 ; Medical sciences ; Muscle, Smooth, Vascular - metabolism ; Muscle, Smooth, Vascular - secretion ; RANTES ; smooth muscle ; TNFα ; Up-Regulation</subject><ispartof>British journal of pharmacology, 1997-10, Vol.122 (4), p.749-757</ispartof><rights>1997 British Pharmacological Society</rights><rights>1997 INIST-CNRS</rights><rights>Copyright 1997, Nature Publishing Group 1997 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5245-6c1d05e92a71b284c9d7f537448236492394d9eef6bfcf745386e72c91e27f893</citedby><cites>FETCH-LOGICAL-c5245-6c1d05e92a71b284c9d7f537448236492394d9eef6bfcf745386e72c91e27f893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564990/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564990/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,1427,27903,27904,45553,45554,46387,46811,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2854378$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9375973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jordan, Nicola J.</creatorcontrib><creatorcontrib>Watson, Malcolm L.</creatorcontrib><creatorcontrib>Williams, Robert J.</creatorcontrib><creatorcontrib>Roach, Alan G.</creatorcontrib><creatorcontrib>Yoshimura, Teizo</creatorcontrib><creatorcontrib>Westwick, John</creatorcontrib><title>Chemokine production by human vascular smooth muscle cells: modulation by IL‐13</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1
The production of chemokines by vascular smooth muscle cells (SMC) is implicated in the pathogenesis of atherosclerosis, although the factors regulating chemokine production by these cells are incompletely characterized.
2
We describe the differential stimulation of interleukin‐(IL)‐8, monocyte chemoattractant protein (MCP)‐1 and regulated on activation normal T‐cell expressed and secreted (RANTES) synthesis following treatment of human vascular SMC with IL‐1α or tumour necrosis factor α (TNFα). Under basal conditions, cultured SMC release very low amounts of IL‐8, MCP‐1 and RANTES as assessed by specific ELISA. Concentration‐response studies with IL‐1α or TNFα revealed that each stimulus induced a similar amount of MCP‐1. In contrast approximately three fold more IL‐8 was induced by IL‐1α than by TNFα whereas significant RANTES production was induced only by TNFα. These findings point to a divergence in the regulation of synthesis of the different chemokines in response to IL‐1α or TNFα stimulation.
3
The T‐cell derived cytokines IL‐10 and IL‐13 were also found to have differential effects on chemokine production by SMC. IL‐13, but not IL‐10, significantly enhanced IL‐8 and MCP‐1 release in response to IL‐1α or TNFα. This increase in chemokine release appeared to be accounted for by increased mRNA expression.
4
These findings provide support for the concept that smooth muscle cells can have an active role in a local immune response via the production of chemokines which can be selectively modulated by T‐cell derived cytokines.
British Journal of Pharmacology (1997) 122, 749–757; doi:10.1038/sj.bjp.0701433</description><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cells, Cultured</subject><subject>Chemokine</subject><subject>Chemokines - biosynthesis</subject><subject>Chemokines - genetics</subject><subject>Chemokines - secretion</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>IL‐10</subject><subject>IL‐13</subject><subject>IL‐8</subject><subject>interleukin (IL)‐1α</subject><subject>Interleukin-10 - pharmacology</subject><subject>Interleukin-13 - pharmacology</subject><subject>MCP‐1</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>Muscle, Smooth, Vascular - secretion</subject><subject>RANTES</subject><subject>smooth muscle</subject><subject>TNFα</subject><subject>Up-Regulation</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU1P2zAYttBQKWxXbkg5TLul-DO2OUzaKj4qVWKTtrPlOA5NceJiN0y98RP4jfwSXDVU7MTJh-fL7_MAcIrgBEEizuNyUi5XE8ghooQcgDGivMgZEegTGEMIeY6QEEfgOMYlTBzO2QiMJOFMcjIGv6cL2_r7prPZKviqN-vGd1m5yRZ9q7vsUUfTOx2y2Hq_XmRtH42zmbHOxYusTQKn3xSz-cvTMyKfwWGtXbRfhvcE_L26_DO9yee317Ppj3luGKYsLwyqILMSa45KLKiRFa8Z4ZQKTAoqMZG0ktbWRVmbmtN0UWE5NhJZzGshyQn4vvNd9WVrK2O7ddBOrULT6rBRXjfqf6RrFurOPyrEkr2EyeDbYBD8Q2_jWrVN3F6mO-v7qLikBAshEnGyI5rgYwy23ocgqLYjqLhUaQQ1jJAEZ--_tqcPrSf864CnerWrg-5ME_c0LBglfJtLdrR_jbObD0LVz183BUk1vQKedqHz</recordid><startdate>199710</startdate><enddate>199710</enddate><creator>Jordan, Nicola J.</creator><creator>Watson, Malcolm L.</creator><creator>Williams, Robert J.</creator><creator>Roach, Alan G.</creator><creator>Yoshimura, Teizo</creator><creator>Westwick, John</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199710</creationdate><title>Chemokine production by human vascular smooth muscle cells: modulation by IL‐13</title><author>Jordan, Nicola J. ; Watson, Malcolm L. ; Williams, Robert J. ; Roach, Alan G. ; Yoshimura, Teizo ; Westwick, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5245-6c1d05e92a71b284c9d7f537448236492394d9eef6bfcf745386e72c91e27f893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cells, Cultured</topic><topic>Chemokine</topic><topic>Chemokines - biosynthesis</topic><topic>Chemokines - genetics</topic><topic>Chemokines - secretion</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>IL‐10</topic><topic>IL‐13</topic><topic>IL‐8</topic><topic>interleukin (IL)‐1α</topic><topic>Interleukin-10 - pharmacology</topic><topic>Interleukin-13 - pharmacology</topic><topic>MCP‐1</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>Muscle, Smooth, Vascular - secretion</topic><topic>RANTES</topic><topic>smooth muscle</topic><topic>TNFα</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jordan, Nicola J.</creatorcontrib><creatorcontrib>Watson, Malcolm L.</creatorcontrib><creatorcontrib>Williams, Robert J.</creatorcontrib><creatorcontrib>Roach, Alan G.</creatorcontrib><creatorcontrib>Yoshimura, Teizo</creatorcontrib><creatorcontrib>Westwick, John</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jordan, Nicola J.</au><au>Watson, Malcolm L.</au><au>Williams, Robert J.</au><au>Roach, Alan G.</au><au>Yoshimura, Teizo</au><au>Westwick, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemokine production by human vascular smooth muscle cells: modulation by IL‐13</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1997-10</date><risdate>1997</risdate><volume>122</volume><issue>4</issue><spage>749</spage><epage>757</epage><pages>749-757</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1
The production of chemokines by vascular smooth muscle cells (SMC) is implicated in the pathogenesis of atherosclerosis, although the factors regulating chemokine production by these cells are incompletely characterized.
2
We describe the differential stimulation of interleukin‐(IL)‐8, monocyte chemoattractant protein (MCP)‐1 and regulated on activation normal T‐cell expressed and secreted (RANTES) synthesis following treatment of human vascular SMC with IL‐1α or tumour necrosis factor α (TNFα). Under basal conditions, cultured SMC release very low amounts of IL‐8, MCP‐1 and RANTES as assessed by specific ELISA. Concentration‐response studies with IL‐1α or TNFα revealed that each stimulus induced a similar amount of MCP‐1. In contrast approximately three fold more IL‐8 was induced by IL‐1α than by TNFα whereas significant RANTES production was induced only by TNFα. These findings point to a divergence in the regulation of synthesis of the different chemokines in response to IL‐1α or TNFα stimulation.
3
The T‐cell derived cytokines IL‐10 and IL‐13 were also found to have differential effects on chemokine production by SMC. IL‐13, but not IL‐10, significantly enhanced IL‐8 and MCP‐1 release in response to IL‐1α or TNFα. This increase in chemokine release appeared to be accounted for by increased mRNA expression.
4
These findings provide support for the concept that smooth muscle cells can have an active role in a local immune response via the production of chemokines which can be selectively modulated by T‐cell derived cytokines.
British Journal of Pharmacology (1997) 122, 749–757; doi:10.1038/sj.bjp.0701433</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>9375973</pmid><doi>10.1038/sj.bjp.0701433</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1188 |
| ispartof | British journal of pharmacology, 1997-10, Vol.122 (4), p.749-757 |
| issn | 0007-1188 1476-5381 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1564990 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cells, Cultured Chemokine Chemokines - biosynthesis Chemokines - genetics Chemokines - secretion Gene Expression Regulation Humans IL‐10 IL‐13 IL‐8 interleukin (IL)‐1α Interleukin-10 - pharmacology Interleukin-13 - pharmacology MCP‐1 Medical sciences Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - secretion RANTES smooth muscle TNFα Up-Regulation |
| title | Chemokine production by human vascular smooth muscle cells: modulation by IL‐13 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A47%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemokine%20production%20by%20human%20vascular%20smooth%20muscle%20cells:%20modulation%20by%20IL%E2%80%9013&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Jordan,%20Nicola%20J.&rft.date=1997-10&rft.volume=122&rft.issue=4&rft.spage=749&rft.epage=757&rft.pages=749-757&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/sj.bjp.0701433&rft_dat=%3Cproquest_pubme%3E79432888%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79432888&rft_id=info:pmid/9375973&rfr_iscdi=true |